{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:16:17Z","timestamp":1788279377949,"version":"build-2803163510"},"reference-count":20,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Health Commission of Anhui Province","award":["AHWJ2025A10063"],"award-info":[{"award-number":["AHWJ2025A10063"]}]},{"award":["AHWJ2025A10063"],"award-info":[{"award-number":["AHWJ2025A10063"]}],"id":[{"id":"https:\/\/ror.org\/01hr4k271","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Oncol.","Current Oncology"],"abstract":"<jats:p>Background: Prostatic adenoid cystic carcinoma\/basal cell carcinoma (ACC\/BCC) has been reclassified under the fifth edition of the World Health Organization\u2019s classification of tumors, distinguishing it from basal cell cancer of the skin. This malignant neoplasm exhibits distinct biological characteristics that differ from those of typical prostatic adenocarcinoma. However, optimal clinical management of prostatic ACC\/BCC remains uncertain because of its rarity and the limited evidence available. Methods: This study retrospectively reviews the treatment course of a 62-year-old male patient presenting with more than six months of dysuria. Initial management included transurethral plasmakinetic resection of the prostate (TUPKP), followed by robot-assisted radical prostatectomy and bilateral pelvic lymph node dissection. Postoperative fluorescence in situ hybridization (FISH) demonstrated MYB rearrangement, providing molecular support for the pathological classification of prostatic ACC\/BCC and facilitating diagnostic reclassification. Results: Pathological examination of the TUPKP specimen indicated poorly differentiated carcinoma, with findings consistent with prostatic ACC\/BCC. Preoperative imaging showed an irregular soft-tissue lesion in the prostate\/bladder neck region, without definite pelvic lymph node or distant organ metastasis. Histological analysis demonstrated cribriform structures and perineural invasion, while immunohistochemistry supported a basal cell phenotype; together with these findings, detection of MYB rearrangement via FISH supported reclassification of the tumor as prostatic ACC\/BCC. Following radical surgery, adjuvant paclitaxel plus carboplatin was administered as an individualized empirical treatment in the absence of an established disease-specific standard. The patient completed six cycles of adjuvant chemotherapy and remained clinically stable during follow-up, with no radiological evidence of recurrence at the latest evaluation. Conclusions: This case highlights the diagnostic challenges of prostatic ACC\/BCC and underscores the value of integrating molecular findings with histopathological and immunohistochemical features to support accurate tumor classification and individualized clinical management. MYB rearrangement may provide useful molecular support for diagnosis and classification; however, its biological and potential therapeutic significance in prostatic ACC\/BCC requires further investigation in larger cohorts.<\/jats:p>","DOI":"10.3390\/curroncol33090527","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:08:43Z","timestamp":1788275323000},"page":"527","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Case of MYB-Rearranged Prostatic Adenoid Cystic Carcinoma"],"prefix":"10.3390","volume":"33","author":[{"given":"Sha","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Liu","sequence":"additional","affiliation":[{"name":"First Clinical Medical College, Anhui Medical University, Hefei 230032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuiping","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China"},{"name":"Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei 230022, China"},{"name":"Institute of Urology, Anhui Medical University, Hefei 230022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Wu","sequence":"additional","affiliation":[{"name":"First Clinical Medical College, Anhui Medical University, Hefei 230032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Fifth Affiliated Hospital of Anhui Medical University, Fuyang 236000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.humpath.2022.08.006","article-title":"The 2022 revision of the World Health Organization classification of tumors of the urinary system and male genital organs: Advances and challenges","volume":"136","author":"Mohanty","year":"2022","journal-title":"Hum. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.eururo.2022.07.002","article-title":"The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs\u2014Part B: Prostate and Urinary Tract Tumors","volume":"82","author":"Netto","year":"2022","journal-title":"Eur. Urol."},{"key":"ref_3","first-page":"187","article-title":"Basal Cell Carcinoma of the Prostate Misdiagnosed as High-Grade Urothelial Cancer\u2013A Case Report of a Diagnostic Pitfall","volume":"15","author":"Taskovska","year":"2023","journal-title":"Res. Rep. Urol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Persson, M., Andersson, M.K., Mitani, Y., Brandwein-Weber, M.S., Frierson, H.F., Moskaluk, C., Fonseca, I., Ferrarotto, R., Boecker, W., and Loening, T. (2022). Rearrangements, Expression, and Clinical Significance of MYB and MYBL1 in Adenoid Cystic Carcinoma: A Multi-Institutional Study. Cancers, 14.","DOI":"10.3390\/cancers14153691"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1038\/s41379-019-0297-6","article-title":"MYB-NFIB gene fusion in prostatic basal cell carcinoma: Clinicopathologic correlates and comparison with basal cell adenoma and florid basal cell hyperplasia","volume":"32","author":"Magers","year":"2019","journal-title":"Mod. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"E292","DOI":"10.1002\/lary.25356","article-title":"MYB rearrangement and clinicopathologic characteristics in head and neck adenoid cystic carcinoma","volume":"125","author":"Rettig","year":"2015","journal-title":"Laryngoscope"},{"key":"ref_7","first-page":"2915","article-title":"Analysis of clinicopathological characteristics, MYB rearrangement and prognostic factors in salivary adenoid cystic carcinoma","volume":"17","author":"Han","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"103722","DOI":"10.1016\/j.esmoop.2024.103722","article-title":"Systemic treatments in recurrent or metastatic salivary gland cancer: A systematic review","volume":"9","author":"Prost","year":"2024","journal-title":"ESMO Open"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/jamaoto.2024.1177","article-title":"Vascular Endothelial Growth Factor Receptor Inhibitors for Recurrent or Metastatic Adenoid Cystic Carcinoma: A Systematic Review and Meta-Analysis","volume":"150","author":"Hoff","year":"2024","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1177\/10668969211017321","article-title":"Basal Cell Carcinoma of Prostate with MSMB\u2013NCOA4 Fusion and a Probable Basal Cell Carcinoma In Situ: Case Report","volume":"29","author":"Pedersen","year":"2021","journal-title":"Int. J. Surg. Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ajpath.2022.09.010","article-title":"Genomic Characterization of Prostatic Basal Cell Carcinoma","volume":"193","author":"Low","year":"2022","journal-title":"Am. J. Pathol."},{"key":"ref_12","first-page":"1519","article-title":"Molecular pathology of adenoid cystic carcinoma","volume":"40","author":"Wei","year":"2025","journal-title":"Histol. Histopathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13046-024-03270-x","article-title":"PRMT5 inhibition has a potent anti-tumor activity against adenoid cystic carcinoma of salivary glands","volume":"44","author":"Mishra","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.humpath.2015.05.002","article-title":"A subset of prostatic basal cell carcinomas harbor the MYB rearrangement of adenoid cystic carcinoma","volume":"46","author":"Bishop","year":"2015","journal-title":"Hum. Pathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/s41416-024-02795-4","article-title":"Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: A systematic review of the last decade","volume":"131","author":"Zhou","year":"2024","journal-title":"Br. J. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.3390\/curroncol29030152","article-title":"Adenoid Cystic Carcinoma\/Basal Cell Carcinoma of the Prostate: Overview and Update on Rare Prostate Cancer Subtypes","volume":"29","author":"Cozzi","year":"2022","journal-title":"Curr. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Dong, S., Liu, Q., Xu, Z., and Wang, H. (2020). An Unusual Case of Metastatic Basal Cell Carcinoma of the Prostate: A Case Report and Literature Review. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.00859"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1200\/JCO.18.01859","article-title":"Phase II Study of Lenvatinib in Patients with Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma","volume":"37","author":"Tchekmedyian","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.1158\/1078-0432.CCR-21-1061","article-title":"Randomized Phase II Study of Axitinib versus Observation in Patients with Recurred or Metastatic Adenoid Cystic Carcinoma","volume":"27","author":"Kang","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1200\/JCO.22.02221","article-title":"Phase II Clinical Trial of Axitinib and Avelumab in Patients with Recurrent\/Metastatic Adenoid Cystic Carcinoma","volume":"41","author":"Ferrarotto","year":"2023","journal-title":"J. Clin. Oncol."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/33\/9\/527\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:21:50Z","timestamp":1788276110000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/33\/9\/527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":20,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["curroncol33090527"],"URL":"https:\/\/doi.org\/10.3390\/curroncol33090527","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}